Predicting major organ complications in primary Sjögren’s disease using a machine learning ensemble strategy: a dual-center retrospective clinical study - Scorecard - MDSpire

Predicting major organ complications in primary Sjögren’s disease using a machine learning ensemble strategy: a dual-center retrospective clinical study

  • By

  • Wenqi Xia

  • Jiayun Wu

  • Jingyu Zhang

  • Yuening Kang

  • Yuling Chen

  • Ruyi Liao

  • Xiaomin Li

  • Ya Wen

  • Shenghui Wen

  • Fanxuan Meng

  • Huifen Liu

  • Zhiyang He

  • Jieruo Gu

  • Ou Jin

  • Yong Ren

  • Qing Lv

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Utilizing a Machine Learning Ensemble Approach to Anticipate Major Organ Complications in Primary Sjögren’s Disease: A Retrospective Study Across Two Centers

At a Glance

CategoryDetail
Condition
Key MechanismsMachine learning algorithms for predicting major organ complications in SjD
Target Population
Care Setting

Key Highlights

  • Ensemble model achieved an AUC of 0.725 and accuracy of 71%
  • Complement C3 and immunoglobulin G (IgG) identified as key predictors
  • Study included 232 newly diagnosed SjD patients
  • Machine learning methods applied for risk stratification

Guideline-Based Recommendations

Diagnosis

  • Utilize routine clinical indicators for early identification of complications

Management

  • Consider personalized management strategies based on identified risk factors

Monitoring & Follow-up

  • Regular follow-up for patients identified at high risk for complications

Risks

  • Low complement C3 and high IgG levels associated with increased complication risk

Patient & Prescribing Data

Further validation and optimization of the model required before clinical implementation.

Clinical Best Practices

  • Incorporate machine learning models for risk stratification in clinical settings
  • Focus on key predictors like complement C3 and IgG for monitoring patient risk

Related Resources & Content

Original Source(s)

Predicting major organ complications in primary Sjögren’s disease using a machine learning ensemble strategy: a dual-center retrospective clinical study

  • by Wenqi Xia, Jiayun Wu, Jingyu Zhang, Yuening Kang, Yuling Chen, Ruyi Liao, Xiaomin Li, Ya Wen, Shenghui Wen, Fanxuan Meng, Huifen Liu, Zhiyang He, Jieruo Gu, Ou Jin, Yong Ren, Qing Lv

  • May 29, 2026

Related Content

Safety and efficacy of combined B-cell depleting therapy and daratumumab in patients with autoimmune encephalitis (RADIA): study protocol for a multicenter, randomized trial

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss